Select Page

What is DCIS?

March 4, 2023

what is DCIS?

ductal carcinoma in situ

by Jamal Ross

There are words in your biopsy report that may be difficult to understand, but there are some key phrases you can learn to help unravel the meaning of this report. First, you will need to become familiar with two terms, which are ductal carcinoma in situ and invasive breast cancer. Let’s find out about ductal carcinoma in situ.

After you receive your biopsy results, you will want to know if the tissue shows cancer cell that invade other structures around it or are confined to an area within the breast duct.  Another name for carcinoma is cancer and another name for situ is local, or “on site.” Therefore, ductal carcinoma in situ, or breast cancer that is local and not spreading, means that there are some changes on your biopsy that suggest cancer, but these cells do invade the structures around it. The breast duct is the passageway where milk travels to reach the nipple after it has been made by special glands within the breast. Cancer tends to occur within the cells that make up this duct. The abbreviation for ductal carcinoma in situ is DCIS. DCIS accounts for 20-25% of all breast cancers. (1) It is thought the DCIS has become more common because we are better able to detect it on mammography; and mammogram has become more widely used over the years. Those with DCIS on a biopsy have a unique treatment pathway that usually does not involve chemotherapy. Let’s find out more about the kinds of treatment that those with DCIS may receive.

Women with DCIS can usually be treated with breast conserving surgery, also known as lumpectomy. With lumpectomy only a portion of the breast is removed and the surgeon works to maintain the aesthetics of your breast without the need for implants. Those with DCIS also require radiation after surgery. If DCIS is larger and a mass can be felt, another biopsy of the lymph nodes may be required to determine if chemotherapy is needed. Also, if DCIS if larger than anticipated, removal of the whole breast may be considered. In fairness, there is some controversy as to whether adding radiation or removing the whole breast is beneficial in women with DCIS.

In addition to knowing the type of cells on your biopsy report, it is also important to know whether these cells respond to estrogen. Breast cancer cells that are responsive to hormones, such as estrogen, tend to have a better outlook.  Fortunately, about 75% of cases of DCIS will be responsive to estrogen (2). If your breast biopsy shows DCIS that is responsive to hormones, a medication called tamoxifen should be considered. Treatment with tamoxifen for 5 years can decrease the recurrence of breast cancer in this case. Yet, there is a small risk of cancer in the lining of the womb, called the endometrium, and blood clots. Although this risk is small, it remains important to discuss treatment with tamoxifen following breast conserving surgery with your doctor.

Understanding your biopsy report can be daunting, but knowing some key words and phrases can help you understand potential treatment options. Ductal carcinoma in situ, or local cancer of the breast duct, does not invade other structures and can be treated with breast conserving surgery and radiation. There are times where DCIS may require another biopsy of the lymph node, chemotherapy or removal of the whole breast. Also, cancer cells that are responsive to estrogen can also be treated with tamoxifen, which has its own risks. Such decisions regarding you care require an in-depth discussion with your doctor. It’s my prayer that after listening to this podcast your will be better equip to ask questions and understand answers that chart a treatment course that leads to a cure.

REFERENCES

1. In Alguire, P. C., & American College of Physicians, (2018). MKSAP 18: Medical knowledge self-assessment program.

2. Hird RB, Chang A, Cimmino V, Diehl K, Sabel M, Kleer C, Helvie M, Schott A, Young J, Hayes D, Newman L. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ. Cancer. 2006 May 15;106(10):2113-8.

Jamal Ross

Dr. Jamal Ross is an internist and pediatrician who possesses a passion for prayer and preventative medicine. He has worked in the fields of primary care and hospital medicine.

Related Posts

Breast Cancer Series Wrap Up & Prayer

Breast Cancer Series Wrap Up & Prayer

Our journey to discover more about breast cancer has been long, but I hope you have learned something that will prevent this disease from taking a hold of your life and those around you. Our breast cancer series cover many areas of this topic including risk factors, symptoms, screening methods, biopsy types, genetic testing and treatment for the most common breast cancer types, specifically DCIS and invasive breast cancer. Let’s review these topics one more time.

What is Invasive Breast Cancer?

What is Invasive Breast Cancer?

As we discussed before, there are words in your biopsy report that may be difficult to understand, but there are some key phrases you can learn to help uncover the meaning of this report. Ductal carcinoma in situ and invasive breast cancer are the two most common types of breast cancer. If you would like to know more about ductal carcinoma in situ, or DCIS, read our blog “What is DCIS?” Otherwise, let’s find out more about invasive breast cancer and discover its meaning.

Genetic Testing

Genetic Testing

There are women and men who are at increased risk for breast cancer. In this group, genetic testing for the BRCA mutation should be a consideration. In this way, other cancers caused by the BRCA mutation can be detected earlier and family members can be empowered to know their cancer risk as well. If you have been diagnosed with breast cancer, you doctor will tell you of you need genetic testing. But for those who are have not been diagnosed with breast cancer, there are some clues you can use to help determine of you need genetic testing.

Breast Cancer Symptoms

Breast Cancer Symptoms

Breast cancer may present in a variety of ways, yet our goal is to detect breast cancer before symptoms begin. In fact, most breast cancers are discovered when a woman has no symptoms. Nonetheless, up to 15% of woman will have breast cancer without a mass found on mammogram. Additionally, another 30% of woman may have a mass found between mammograms. Knowing the signs of breast cancer is an extra step you can step to help know if you at risk for this disease.

Comments

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *